For one, you are wrong on the Fadogia Agrestis front - in fact, most of the studies done on the plant involve the stem, not the root, however the constituents are of course also evident in the root. But I digress; the certain glycosides we were looking to target are also isolated from the leaves, as evidenced here: Invalid Link Removed. We specify plant extract, but not isolated for any one compound so it includes a spectrum of glycosides and other actives that contribute to certain effects. These glycosides are, shock horror, also found in Anacyclus - which you advocate for. Would you mind linking me to the actives that are only present in the root that are responsible for leydig cell function? That would be appreciated.
Secondly, we ran with Urtica Diocia because of its binding affinity to SHBG, however this paper may be of interest to you: Invalid Link Removed
This paper is titled: Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial.
With another one here: Invalid Link Removed
The outcome may surprise you.
Of course the 'rep' was not going to divulge the suppliers to you - majority of companies won't. This isn't unique to CEL/ SNS, but the industry as a whole. To then imply we are trying to deceive our customers is quite frankly insulting. Perhaps you didn't intend it that way, but the way you word your posts comes across that way.
I'm happy with the profile of M Test, and will happily back up each component of the profile if challenged.